GE HealthCare Technologies Inc. with ticker code (GEHC) now have 13 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $105.00 and $86.00 suggesting an average Analsyt target price of $93.71. Given that the stocks previous close was at $83.40 this indicates there is a potential upside of 12.4%. The 50 day moving average now sits at $87.02 and the 200 day moving average is $76.22. The total market capitalization for the company now stands at 36.99B. The current share price for the company is: $81.03 USD
The potential market cap would be $41,559,777,382 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 23.56, revenue per share of $42.80 and a 5.63% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
